fda import alert semaglutide green list Compounded & Tirzepatide 2025: Safe Use Guide FDA Issues Import Alert on

The Trump administration announced initiatives in November 2025 to expand GLP-1 access for Medicare beneficiaries with obesity plus significant comorbidities, with implementation expected around mid-2026

Traditional pharmacy channels, primary care prescribing, or manufacturer patient assistance programs would be more appropriate paths

I have more energy throughout the day and feel better keeping up with family

For those struggling with weight loss, semaglutide offers an effective solution that supports better control over eating and lasting weight management

In addition, liraglutide provided multiple additional benefits by reducing the incidence of hypoglycemia, lowering HbA1c and functioning through multiple mechanisms to better control multiple causes of MACE, such as blood lipids, BP as well as body weight (BW)

Over-restricting calories